Company name: Sinopsys Surgical, also known as DCS Surgical Inc.
Industry: Medical devices (surgery).
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Location: Boulder, Colorado.
Solution/product: Currently in stealth mode, the company is developing minimally invasive surgical technology for the lacrimal system, which comprises structures for tear production and drainage.
Money raised: Half of a $2.4 million equity offering.
Investors: The U.S. Securities and Exchange Commission filing lists directors from DFJ Mercury, High Country Venture and Aweida Venture Partners.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Management team: CEO Harry Ross is a former partner at Aweida Venture Partners.
Competitors: Quest Medical, FCI Ophthalmics and Sterimedix also make devices for blocked tear ducts.